Warfarin - How Good Are we at Maintaining Target Range ?
|ClinicalTrials.gov Identifier: NCT01081327|
Recruitment Status : Unknown
Verified March 2010 by University of Dundee.
Recruitment status was: Active, not recruiting
First Posted : March 5, 2010
Last Update Posted : June 25, 2010
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||5000 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Observational Record Linkage Study Investigating Incidence of Adverse Events in Patients Anti-coagulated for Lone Atrial Fibrillation.|
|Study Start Date :||March 2010|
|Estimated Primary Completion Date :||March 2011|
|Estimated Study Completion Date :||March 2011|
|Patients receiving Warfarin|
- Bleeding Complication [ Time Frame: 10 years ]Any bleeding event requiring hospitalisation and / or blood transfusion. Any death attributable to bleeding i.e. Intracerebral bleed.
- Cardiovascular outcome [ Time Frame: 10 years ]Ischaemic event e.g. Cerebral infarction / Myocardial infarction / death attributed to ischaemic event
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01081327
|Centre for Cardiovascular and Lung Biology, Univeristy of Dundee|
|Dundee, United Kingdom, DD1 9SY|